AzTrials
AzTrials

Suicide, AttemptedMAPPSNCT04085848

Music Against Psychological Pain in Suicide

A study testing music therapy in people with Suicide, Attempted and Suicidal Ideation, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study compares the efficacy of music therapy associated with standard care versus the standard care alone on the psychological pain in suicidal patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicide, Attempted, Suicidal Ideation
What is being tested?
music therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
264 participants
Where
1 siteReunion
Study dates
25 Feb 2020to Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient with suicidal ideas, thoughts or surviving suicide attempt
  • Patient whose emergency somatic management lasted less than 48h
  • Patient who, according to the physician, is still in suicidal mood
  • Patient admitted in the psychiatric hospitalization unit of the Public Mental Health Establishment
  • Patient with voluntary admission and agrees to stay in hospital from 48h to 60h
  • Patient able to write and read in french
  • Patient affiliated to a social security scheme
  • Patient who gives his Informed consent before any procedure related to the study

Who cannot join

  • Patient with attempt suicide requiring a somatic care (intensive, surgery, gastric lavage...)
  • Patient with medical history of audiogenic and/or musicogenic epilepsy
  • Patient with major impairment of hearing function
  • Patient unable to support the headhset earphone
  • Patient with contra indication to BZD, hypnotics (Zopiclone) or requiring more sedative and/or psychotic drugs
  • Patient under guardianship or under judicial protection
  • Patient hospitalized at the request of a third party or ex officio

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Reunion1 site, 1 recruiting
  • Etablissement Public de Santé Mentale de La Réunion

    Saint-Paul, 97460

    Erick GOKALSING

    Erick GOKALSING, MD

    Recruiting

Other trials in Reunion

About this study

Official title: A Controlled, Randomized Study Evaluating the Effecacy of Receptive Music Therapy on Psychological Pain in Suicidal Patients

This study compares the efficacy of music therapy associated with standard care versus the standard care alone on the psychological pain in suicidal patients.

Read the detailed description

Music therapy consists of using the Music Care tool. Each patient randomized in the music therapy arm should perform 4 music therapy sessions of 30 minutes on 48h.

Before and after each music therapy sessions, the psychological pain will be measured by the analogical visual scale.

Standard care consists of a medical and paramedical interview lasting 20-30 minutes. At the end of the interview, a drug treatment (BZD anxiolytic and/or hypnotic) is prescribed and the patient is hospitalized. During hospitalization, patient is regularly interviewed in order to evaluate his psychological status.

Being tested
music therapy
Medical subject headings
Suicide, Attempted, Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • music therapyOther

    4 music therapy sessions during a period of time of 48 hours. Each session lasts 30 minutes.

Study groups in NCT04085848
Study groupRoleWhat they receive
Groupe interventionExperimentalUsual care and music therapy
Receives: Other: music therapy
Groupe contrôleNo interventionUsual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from inclusion psychological pain at 48 hours after inclusion

    Pain analogical visual scale (scale ranges : from 0 to 10) min = 0 = no psychological pain and max = 10 = maximum psychological pain

    Measured: 48 hours after inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start25 Feb 2020
  3. Primary completionNov 2027 (estimated)
  4. Study completionNov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
264 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04085848
Sponsor's protocol ID
2017/CHU/19
Acronym
MAPPS
Status last verified
Sep 2026
First submitted
3 Sep 2019
Last updated
14 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing music therapy in people with Suicide, Attempted and Suicidal Ideation, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Reunion. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emilie TECHER (+2 62 262 90 62 89, emilie.techer@chu-reunion.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from inclusion psychological pain at 48 hours after inclusion (time frame: 48 hours after inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in